StockData
Linde PLC logo

Linde PLC (LIN) operating KPIs

LINNasdaqIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 16/3037% above fair value
$514.24+11.09 (+2.20%)

Close on Oct 30, 2026Market cap $237.05BP/E 34.1Yield 1.17%

Linde u.S. Industrial Production: Pharmaceuticals & Medicine (NAICS 3254) (×)

Fed G.17 / FRED

Latest, Sep 2026
124.27
Period ended Sep 30, 2026
Change on a year earlier
+2.5%
121.27 in Sep 2025
History
117 months
Since Jan 2017
Sources
1
Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S)

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. Industrial Production: Pharmaceuticals & Medicine (NAICS 3254) (×)Year on yearSource
Sep 2026Sep 30, 2026124.27+2.5%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Aug 2026Aug 31, 2026122.50+0.4%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Jul 2026Jul 31, 2026122.23-0.1%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Jun 2026Jun 30, 2026120.90+1.1%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
May 2026May 31, 2026119.12+0.8%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Apr 2026Apr 30, 2026121.28+1.2%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Mar 2026Mar 31, 2026120.99+1.1%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Feb 2026Feb 28, 2026120.07+2.0%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Jan 2026Jan 31, 2026119.10+3.3%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Dec 2025Dec 31, 2025119.37+5.1%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Nov 2025Nov 30, 2025120.13+4.9%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Oct 2025Oct 31, 2025121.96+6.1%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Sep 2025Sep 30, 2025121.27+5.6%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Aug 2025Aug 31, 2025122.04+6.3%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Jul 2025Jul 31, 2025122.39+6.7%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗
Jun 2025Jun 30, 2025119.59+6.7%Federal Reserve Board (G.17): U.S. Industrial Production: Pharmaceuticals & Medicines (NAICS 3254) (IPG3254S) ↗

Cite this data

StockData. (2026). Linde U.S. Industrial Production: Pharmaceuticals & Medicine (NAICS 3254) (×), monthly Jan 2017–Sep 2026 [Data set]. Compiled from Linde SEC filings and investor materials. https://stockdatahq.com/stocks/lin/kpis/macro_ip_pharma

See every metric in the Linde KPI table. Data updated Oct 31, 2026.